Trial Profile
Use of vildagliptin and sulfonylurea therapy, with and without metformin,in Indian patients with type 2 diabetes mellitus during the Ramadan fast.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2011
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis